Biggest News Aggregation in the World
๐Ÿ“ฐ Checkpoint Blockade News

Checkpoint Blockade News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Checkpoint Blockade. Real-time updates on events, politics, business and more.

It's not about grain but about politics – Zelenskyy assesses crisis on Polish border

Ukrainian President Volodymyr Zelenskyy has criticised the checkpoint blockade on the Polish-Ukrainian border by the Polish farmers, calling for joint rational solutions of this situation. Source: European Pravda with reference to the evening address of Zelenskyy Details: Zelenskyy stated that the events on the Polish-Ukrainian border "cannot be treated as something normal or routine".
Volodymyr Zelenskyy Ukrainian President Volodymyr Zelenskyy European Pravda Polish Border Polish Farmers Checkpoint Blockade
Source: yahoo.com

TriSalus Life Sciences Announces Late Breaker and Additional Data Presentations on Liver Metastases and Pancreatic Cancer at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

TriSalus Life Sciencesยฎ Inc., , an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today announced...
United States San Diego Chandrac Ghosh Sapanp Patel Michaels Lee University Of Texas Md Anderson Cancer Center

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

BioInvent & Transgene Joint JITC Publication Demonstrates the Potential of BT-001 Oncolytic Virus to Provide Therapeutic Benefit Beyond Current Anti-PD-1/ Anti-CTLA-4 Immune Checkpoint Blockade

20.01.2022 - LUND, SWEDEN / ACCESSWIRE / January 20, 2022 / BioInvent International (STO:BINV)Preclinical proof-of-concept data published in the January 20, 2022 edition of the Journal for ImmunoTherapy of Cancer (JITC)BioInvent International AB (BioInvent) ... Seite 1
Bjorn Frend Bioinvent International Bioinvent International Ab Nasdaq Stockholm Bioinvent International Ab Transgene Joint Provide Therapeutic Benefit Beyond Current

Study seeks to identify biological markers that predict mesothelioma response to treatment

ย E-Mail The National Cancer Institute (NCI) has granted a $2.5 million, five-year R37 MERIT Award to Dr. Bryan Burt, associate professor of surgery and chief of the Division of General Thoracic Surgery, for his research project titled, "Proteomic Determinants of Response to Checkpoint Blockade in Malignant Pleural Mesothelioma." "Malignant pleural mesothelioma (MPM) is a fatal cancer of the lining of the lungs that has defeated standard therapies for decades. In recent years, emerging clinical...
Bryan Burt National Cancer Institute National Institutes Of Health General Thoracic Surgery Checkpoint Blockade Malignant Pleural Mesothelioma

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science